H

HARBOUR BIOMED

111 employees

Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunology
immuno-oncology
Pharmaceutical
B-Cell Cloning
Biopharma
transgenic mouse technology

Date founded

2016

Investments made

U

Undisclosed raised undisclosed on January 26, 2023

Investors: HARBOUR BIOMED

Funding rounds raised

Total raised

$103M

from 17 investors over 17 rounds

H

HARBOUR BIOMED raised $103M on July 9, 2020

Investors: Octagon Capital, 碧桂园集团, OrbiMed Advisors and Hudson Bay Capital Management LP

H

HARBOUR BIOMED raised $75M on March 12, 2020

Investors: Zhejiang University of Media and Communications, GIC, Efung Capital, Legend Capital and Zheshang Venture Capital

H

HARBOUR BIOMED raised $85M on August 27, 2018

Investors: 祥恩股权投资管理(上海)有限公司, Sovereign Wealth Fund Institute Inc., GIC and Legend Capital

H

HARBOUR BIOMED raised undisclosed on January 22, 2018

Investors: Atlas Venture, Legend Capital and CDH Investments

H

HARBOUR BIOMED raised $50M on December 19, 2016

Investors: Legend Capital

FAQ